Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Johan, Eide"'
Autor:
Gøril Knutsvik, Ingunn M Stefansson, Sura Aziz, Jarle Arnes, Johan Eide, Karin Collett, Lars A Akslen
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e112121 (2014)
Tumor cell proliferation in breast cancer is strongly prognostic and may also predict response to chemotherapy. However, there is no consensus on counting areas or cut-off values for patient stratification. Our aim was to assess the matched level of
Externí odkaz:
https://doaj.org/article/4f22fe5d28864c9c97791e944ee02145
Autor:
Hilde Kollsete Gjelberg, Anders Molven, Caroline S. Verbeke, Johan Eide, Dag Hoem, John G. Cooper
Publikováno v:
Clinical Case Reports
Key Clinical Message Insulinomas are uncommon tumors, and in patients with diabetes mellitus they are extremely rare. We describe a patient with type 1 diabetes who developed malignant insulinoma. When hypoglycemic episodes persist in a patient with
Autor:
Signe Ingvarsen, Clement S. Trovik, Andreas Hald, Kirstine S Nørregaard, Ole Didrik Laerum, Niels Behrendt, Johan Eide, Morten Persson, Thomas H. Bugge, Henrik J. Jürgensen, Christoffer Nielsen, Daniel H. Madsen, Kristina Johansson, Maria C. Melander, Andreas Kjaer, Lars H. Engelholm
Publikováno v:
The Journal of Pathology. 238:120-133
In osteosarcoma, a primary mesenchymal bone cancer occurring predominantly in younger patients, invasive tumour growth leads to extensive bone destruction. This process is insufficiently understood, cannot be efficiently counteracted and calls for no
Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients
Autor:
Kjell Øvrebø, Ingvild K. Elde, Hans Kristian Haugland, Pehr Rissler, Martin Almquist, Linn H. Trovik, Jacob Engellau, Johan Eide, Nina L. Jebsen, Odd R. Monge, Anniken B. Nyhus
Publikováno v:
Acta Oncologica. 53:1165-1172
Currently there is no consensus on the use of adjuvant radiotherapy (RT) in retroperitoneal sarcoma (RPS). We have analysed clinical outcomes in patients with localised RPS treated at two Scandinavian Sarcoma Group (SSG) centres: Haukeland University
Publikováno v:
The Journal of Pathology
Publikováno v:
Acta Pathologica Microbiologica Scandinavica Section C Immunology. :93-99
A 13-year-old girl with no previously known predisposing disease developed phycomycosis involving the left lung, pleura and shoulder, the left side of the neck, the left thigh, the kidney sand the brain. Prolonged amphotericin B therapy resulted in c
Autor:
Lars H, Engelholm, Maria C, Melander, Andreas, Hald, Morten, Persson, Daniel H, Madsen, Henrik J, Jürgensen, Kristina, Johansson, Christoffer, Nielsen, Kirstine S, Nørregaard, Signe Z, Ingvarsen, Andreas, Kjaer, Clement S, Trovik, Ole D, Laerum, Thomas H, Bugge, Johan, Eide, Niels, Behrendt
Publikováno v:
The Journal of pathology. 238(1)
In osteosarcoma, a primary mesenchymal bone cancer occurring predominantly in younger patients, invasive tumour growth leads to extensive bone destruction. This process is insufficiently understood, cannot be efficiently counteracted and calls for no
Autor:
Ariel P Otte, Jarle B. Arnes, Ingunn M. Stefansson, Audun Braaten, Karin Collett, Lars A. Akslen, Geir Egil Eide, Johan Eide, Turid Aas
Publikováno v:
Clinical Cancer Research, 12, 1168-1174. American Association for Cancer Research Inc.
The polycomb group protein enhancer of zeste homologue 2 (EZH2) has been linked to invasive properties of aggressive breast cancer. In this report, tissue microarray analysis of 190 breast carcinomas from a nested case-control study shows that EZH2 i
Autor:
Karin Collett, Lars A. Akslen, Audun Braaten, Geir Egil Eide, William D. Foulkes, Johan Eide, Ingunn M. Stefansson, Hege Wang, Steinar Thoresen
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 14:1108-1112
Interval breast cancer reduce the effectiveness of mammography screening programs. We studied 95 interval cancers, diagnosed during 1996 to 2001 as part of the population-based Norwegian Breast Cancer Screening Program. These cases were matched on si
Autor:
Johan Eide, Tore Wentzel-Larsen, Per Aage Hoisaeter, Peder Gjengstø, Lars A. Akslen, Elisabeth Paus, Ole J. Halvorsen
Publikováno v:
Journal of Urology. 173:425-428
To our knowledge we introduce the ROC partial area under the curve (AUC) index as a method of evaluating the discriminative power of different prostate cancer predictors. Peripheral zone volume and peripheral zone prostate specific antigen (PSA) dens